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Background and aims: Few studies have assessed cell-mediated immunity in preterm infants. This study 
aimed to compare cellular immune responses to vaccination against measles, varicella-zoster and tetanus in 
preterm and term infants. 
 
Methods: Two prospective cohorts of infants (Group 1: 61 infants; BW: 1184±214g; GA: 30±2.2wks); 
Group 2, 53 infants, BW: 3245±285g; GA: 39±1wk) aged 12-18 months were vaccinated with measles 
vaccine at 12mo and tetanus booster and varicella-zoster at 15mo. Response to measles, varicella-zoster and 
tetanus was evaluated by IFN-gamma production by CD4 and CD8 T cells by flow cytometry. Cell 
percentages were compared by t-test after logarithmic transformation; p< 0.05 was considered significant.  
 
Results: Preterm and full-term infants had similar IFN-gamma production by CD4 and CD8 T cells after 
measles, varicella-zoster and tetanus vaccination. 
 
 
IFN-gamma producing 
cells (%) 
Preterm Term p 
Measles IFN-gamma CD4 0.722±1.321 2.203±8.894 0.205 
Measles IFN-gamma CD8 1.683±2.281 4.337±8.762 0.062 
Varicella IFN-gamma 
CD4 
1.147±2.562 1.139±2.730 0.870 
Varicella IFN-gamma 
CD8 
1.978±4.491 2.082±4.106 0.832 
Tetanus IFN-gamma CD4 1.554±6.016 0.736±3.328 0.620 
Tetanus IFN-gamma CD8 1.974±4.779 1.167±3.544 0.520 
[IFN-gamma production after vaccination] 
 
 
Reactivity to phyto-hemagglutinin by CD4 and CD8 T cells increased significantly from 12-15mo and 12-
18mo of age in Group 1, but not in Group 2.  
 
Conclusions: Except by phyto-hemagglutinin activation, term and preterm infants had similar cellular 
immune response after vaccination. 
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